HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is based in Port Moody, Canada.
Frequently asked questions
What sector does HAVN Life Sciences Inc (HAVN) operate in?
HAVN Life Sciences Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is HAVN Life Sciences Inc (HAVN) current stock price?
As of the latest data, HAVN Life Sciences Inc stock price is CA$0.03, with a previous close of CA$0.03.
What is HAVN Life Sciences Inc (HAVN) current market capitalization?
HAVN Life Sciences Inc market cap is approximately 442.16 thousand.
What is HAVN Life Sciences Inc (HAVN) Earnings Per Share (EPS)?
The trailing EPS is -CA$3.11.
Does HAVN Life Sciences Inc (HAVN) pay dividends?
No. HAVN Life Sciences Inc does not pay a dividend.
What is HAVN Life Sciences Inc (HAVN) beta (volatility) score?
HAVN Life Sciences Inc has a beta of -0.767, indicating lower volatility than the overall market.
